Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer

INTRODUCTION: There are no reliable blood biomarkers for monitoring endometrial cancer patients in the current clinical practice. Circulating tumor DNA (ctDNA) is emerging as a promising non-invasive method to measure tumor burden, define prognosis and monitor disease status in many solid cancers. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassi, Tommaso, Harris, Faye R., Smadbeck, James B., Murphy, Stephen J., Block, Matthew S., Multinu, Francesco, Schaefer Klein, Janet L., Zhang, Piyan, Karagouga, Giannoula, Liu, Minetta C., Larish, Alyssa, Lemens, Maureen A., Sommerfield, Marla Kay S., Cappuccio, Serena, Cheville, John C., Vasmatzis, George, Mariani, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192008/
https://www.ncbi.nlm.nih.gov/pubmed/34111149
http://dx.doi.org/10.1371/journal.pone.0252390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192008/
https://www.ncbi.nlm.nih.gov/pubmed/34111149
http://dx.doi.org/10.1371/journal.pone.0252390

Ejemplares similares